FDA Clearance Tracker · K243245
IceSeed 1.5 CX Straight Needle (H7493968333170); IceSphere1.5 CX Straight Needle (H7493968435730); IceRod 1.5 CX Straight Needle (H7493968535330)
Last checked: Nov 19, 2026Latest source record: Oct 18, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 18, 2024
Substantially Equivalent
Time to decision
7 days
Received Oct 11, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243245
- Device name
- IceSeed 1.5 CX Straight Needle (H7493968333170); IceSphere1.5 CX Straight Needle (H7493968435730); IceRod 1.5 CX Straight Needle (H7493968535330)
- Applicant
- Boston Scientific Corp
- Applicant location
- Maple Grove, MN
- Received
- Oct 11, 2024
- Decided
- Oct 18, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Unit, Cryosurgical, Accessories (GEH)
- Device class
- Class II
- Regulation
- 21 CFR 878.4350
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GEH. The earliest in FDA's data is K760353, decided Oct 29, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243245
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure Technology, WATCHMAN FLX Left Atrial Appendage Closure Device with DeliPMA supplement
P130013-S074 · Decided Jul 16, 2025 · 180 days after receipt · Panel Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
P150031-S064 · Decided Feb 29, 2024 · 153 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.